Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2030 of 6351
-
New combo therapy shows promise for rare blood cancers
Disease control OngoingThe aim of this study is to observe and analyze the clinical efficacy of Venetoclax+HMAs regimen in the treatment of newly diagnosed higher-risk MDS and CMML cases, and to compare the efficacy of venetoclax +HMAs regimen with that of HMAS regimen alone, in order to provide a norm…
Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can extreme heat or cold raise the risk of workplace accidents?
Knowledge-focused OngoingThis study will determine whether extreme ambient temperatures increase the incidence and severity of occupational injuries in Israel, and we request Helsinki Committee approval to conduct the analysis using de-identified National Insurance and historical meteorological data, wit…
Sponsor: Sergio Gabriel Susmallian • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Massive study seeks to unlock best Post-Surgery care for lung cancer patients
Knowledge-focused OngoingThe aim of this observational study is to investigate the survival differences among patients with non-small cell lung cancer who received different adjuvant treatments after neoadjuvant immunotherapy, and to identify the main clinical characteristics of these survival difference…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New 'Smart' cut during ERCP aims to slash complication rates
Disease control CompletedThis study compares endoscopic transpapillary antegrade sphincterotomy developed by Dr. Dovbenko (Antegrade Sphincterotomy Dovbenko, ASD) with conventional pull-type endoscopic sphincterotomy (EST) in patients undergoing transpapillary interventions for various indications, inclu…
Sponsor: Military Medical Clinical Center of the Southern Region, Ukraine • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could zapping the brain rapidly reduce suicidal urges?
Symptom relief OngoingThis is a pilot study to analyze the benefit of accelerated continuous Transcranial magnetic stimulation for inpatient subjects suffering with suicidal ideation. This study will enroll 40 inpatient subjects recruited from the Resnick Neuropsychiatric hospital. Subjects will be bl…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can a robot unlock the Brain's recovery after stroke?
Knowledge-focused Recruiting nowThe acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb. The aims of this research program are: 1. To test the c…
Sponsor: University Hospital of Mont-Godinne • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Virus plus radiation may shrink sarcomas before surgery
Disease control OngoingThis phase II trial studies the side effects of talimogene laherparepvec and radiation therapy and to see how well they work in treating patients with newly diagnosed soft tissue sarcoma that can be removed by surgery (resectable). Biological therapies, such as talimogene laherpa…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New dissolving film shows promise for agitation in dementia
Symptom relief CompletedThis is an adaptive Phase 1b/2 trial design. It is randomized, double-blind, placebo-controlled, multiple ascending dose study assessing efficacy, pharmacokinetics, safety and tolerability of BXCL-501 dosing in adult (65 years and older) males and females with acute agitation ass…
Phase 1/2 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
One and done? single radiation dose before breast cancer surgery tested
Disease control OngoingThe purpose of this phase I trial is to evaluate dose-limiting toxicity while dose escalating single-fraction preoperative S-PBI to a presumed radioablative dose over 3 cohorts, starting with 30Gy in 1 fraction and advancing to 34Gy and 38Gy in 1 fraction.
Phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:43 UTC
-
New dual brain implant aims to stop severe tremors
Disease control Recruiting nowThis is a feasibility study based on physician-initiated Investigational Device Exemption (IDE) including intraoperative experiments and chronic testing of implanted dual thalamic DBS lead systems. This study will inform protocols for optimal use of implanted next-gen DBS systems…
Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New PET tracer may solve brain scan mystery after radiation
Diagnosis Recruiting nowThis study aims to evaluate the diagnostic potential of 68-Gallium PSMA-PET/CT in stereotactic irradiated brain metastases from non-small cell lung cancer, melanoma and breast cancer.
Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
Daily injection shows promise for Long-Term control of rare muscle disease
Disease control CompletedThe RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Freezing cancer cells: could cryoablation boost immunotherapy?
Disease control OngoingThis interventional trial studies the effectiveness of adding cryoablation treatment in patients who are receiving standard of care immunotherapy to treat cancer that is has spread to other parts of the body (metastatic). Cryoablation uses a probe that freezes the tissue around t…
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug aims to shrink brain tumors by blocking cancer's growth signal
Disease control OngoingThis phase I trial studies the side effects and best dose of WSD0922-FU for the treatment of glioblastoma, anaplastic astrocytoma, or non-small cell lung cancer that has spread to the central nervous system (central nervous system metastases). WSD0922-FU is a targeted treatment w…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for polycythemia vera patients who Can't use standard drugs
Disease control CompletedThis is a Phase 2 single arm study to investigate efficacy and safety of P1101 for adult Japanese patients with PV.
Phase 2 • Sponsor: PharmaEssentia Japan K.K. • Aim: Disease control
Last updated Jun 26, 2026 17:14 UTC
-
New hope for kids on dialysis: drug targets overactive glands
Disease control Recruiting nowAssess the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of etelcalcetide in the treatment of secondary hyperparathyroidism (SHPT) in pediatric participants between ≥ 2 to \< 18 years of age, with chronic kidney disease (CKD) on hemodialysis.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Kids with psoriasis get extended relief in new drug study
Disease control CompletedThis study was created to provide subjects who complete Week 52 (end of Apremilast Extension Phase) of study CC-10004-PPSO-003 the option to continue to receive open-label apremilast therapy. The study will consist of up to 208 weeks of long-term treatment followed by an 8-week …
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
10,000 genomes scoured for clues to rare brain diseases
Knowledge-focused By invitation onlyThe project is focused on the detailed study of structural genomic variants (SVs). Such genetic mutations are in fact alterations in the DNA molecule structure and include copy number variants, inversions and translocations. A single event may affect many genes as well as regulat…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:56 UTC
-
Could a gel cut down on skin cancer surgeries? new trial investigates
Disease control Stopped earlyThis is a multicenter, randomized, double-blind, stratified, vehicle-controlled study of the efficacy and safety of Patidegib Topical Gel, 2%, applied topically twice daily to the face of adult participants with non-Gorlin HF-BCC (high-frequency basal cell carcinoma). Participant…
Phase 2 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Lung cancer umbrella study aims to match treatments to tumor type
Knowledge-focused Recruiting nowThis study is referred to as the "umbrella master protocol" for pembrolizumab (MK-3475) in the treatment of non-small cell lung cancer (NSCLC). This pembrolizumab NSCLC umbrella master protocol uses a platform design and consists of this master screening study and additional subs…
Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC